Harnessing targeted DNA methylation and demethylation using dCas9

Area of Science:

• Epigenetics
• Molecular Biology
• Genomics

Background:

• DNA methylation is a critical epigenetic modification regulating gene expression during development.
• Aberrant DNA methylation patterns are implicated in various disease states.
• CRISPR/catalytically dead CRISPR/Cas9 (dCas9)-based tools offer novel approaches to study DNA methylation.

Purpose of the Study:

• To review the current landscape of targeted DNA methylation editing technologies.
• To discuss the advantages and limitations of existing tools.
• To outline future directions for advancing DNA methylation editing.

Main Methods:

• Utilizing CRISPR/dCas9 fusion proteins with methyltransferases or demethylases.
• Employing guide RNAs for precise targeting of specific genomic loci.
• Analyzing the impact of targeted methylation changes on gene expression and cellular function.

Main Results:

• CRISPR/dCas9 tools have provided new insights into the functional roles of DNA methylation at regulatory regions.
• These tools have facilitated the study of aberrant methylation in disease models.
• Current tools face challenges in achieving high efficacy, specificity, and ease of implementation.

Conclusions:

• Targeted DNA methylation editing is a powerful approach for understanding epigenetic regulation.
• Continued technological development is crucial for overcoming current limitations.
• Advancements hold promise for improved disease modeling and therapeutic strategies.